In early 2024, the FDA approved continuous glucose monitoring devices for people without diabetes for the first time. It’s eminently understandable why people living with diabetes would need to keep a ...

DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...